
Procter & Gamble (PG) is recommended as a buy with a price target of $163.50, implying a 14.95% upside from its current price of $142.24. Despite a recent share price decline, PG reported solid Q3 FY2026 earnings beating expectations with revenue growth of 7.4% year-over-year. The company’s growth is supported by innovation, cost-saving initiatives, and expanding markets, particularly in emerging regions. Risks include tariff impacts and margin pressures, but overall PG offers defensive stability, dividend growth, and potential for long-term gains up to $224 by 2030 if current strategies succeed.